effect of high dose of atorvastatin after angioplasty in patients with stable angina
Not Applicable
- Conditions
- stable angina.Chronic ischaemic heart disease
- Registration Number
- IRCT2016060418741N2
- Lead Sponsor
- Mazandaran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 469
Inclusion Criteria
patients with stable angina that nominated for coronary angioplasty Exclusion criteria: acute coronary syndrome (unstable angina, non ST elevation myocardial infarction, ST elevation myocardial infarction); bare stent angioplasty; balloon angioplasty; angioplasty on saphenous vein graft; liver disease
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major adverse cardiovascular and cerebrovascular events. Timepoint: 6 month after procedure. Method of measurement: Questionnaire.;All cause mortality. Timepoint: 6 month after procedure. Method of measurement: Questionnaire.;Myocardial infarction. Timepoint: 6 month after procedure. Method of measurement: Questionnaire.;Stroke. Timepoint: 6 month after procedure. Method of measurement: Questionnaire.;Target lesion revascularization. Timepoint: 6 month after procedure. Method of measurement: Questionnaire.;Target vessel revascularization. Timepoint: 6 month after procedure. Method of measurement: Questionnaire.;Acute coronary syndrome. Timepoint: 6 month after procedure. Method of measurement: Questionnaire.;At least 3 times increase of liver enzyme. Timepoint: 3 , 6 month after procedure. Method of measurement: miligram per deciliter.;At least 3 times increase of mascular enzyme. Timepoint: 3 , 6 month after procedure. Method of measurement: miligram per deciliter.
- Secondary Outcome Measures
Name Time Method ow density lipoprotein (LDL). Timepoint: end of study. Method of measurement: miligram per deciliter.;Total cholesterol. Timepoint: end of study. Method of measurement: miligram per deciliter.;High density lipoprotein (HDL). Timepoint: end of study. Method of measurement: miligram per deciliter.;Triglyceride. Timepoint: end of study. Method of measurement: miligram per deciliter.;Total cholesterol to HDL. Timepoint: end of study. Method of measurement: miligram per deciliter.